Literature DB >> 23404175

A mutation in the start codon of γ-crystallin D leads to nuclear cataracts in the Dahl SS/Jr-Ctr strain.

Ashley C Johnson1, Jonathan W Lee, Ashlyn C Harmon, Zaliya Morris, Xuexiang Wang, Jonathan Fratkin, John P Rapp, Elise Gomez-Sanchez, Michael R Garrett.   

Abstract

Cataracts are a major cause of blindness. The most common forms of cataracts are age- and UV-related and develop mostly in the elderly, while congenital cataracts appear at birth or in early childhood. The Dahl salt-sensitive (SS/Jr) rat is an extensively used model of salt-sensitive hypertension that exhibits concomitant renal disease. In the mid-1980s, cataracts appeared in a few animals in the Dahl S colony, presumably the result of a spontaneous mutation. The mutation was fixed and bred to establish the SS/Jr-Ctr substrain. The SS/Jr-Ctr substrain has been used exclusively by a single investigator to study the role of steroids and hypertension. Using a classical positional cloning approach, we localized the cataract gene with high resolution to a less than 1-Mbp region on chromosome 9 using an F1(SS/Jr-Ctr × SHR) × SHR backcross population. The 1-Mbp region contained only 13 genes, including 4 genes from the γ-crystallins (Cryg) gene family, which are known to play a role in cataract formation. All of the γ-crystallins were sequenced and a novel point mutation in the start codon (ATG → GTG) of the Crygd gene was identified. This led to the complete absence of the CRYGD protein in the eyes of the SS/Jr-Ctr strain. In summary, the identification of the genetic cause in this novel cataract model may provide an opportunity to better understand the development of cataracts, particularly in the context of hypertension.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23404175      PMCID: PMC3628938          DOI: 10.1007/s00335-013-9447-1

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  47 in total

1.  Genome scan and congenic strains for blood pressure QTL using Dahl salt-sensitive rats.

Authors:  M R Garrett; H Dene; R Walder; Q Y Zhang; G T Cicila; S Assadnia; A Y Deng; J P Rapp
Journal:  Genome Res       Date:  1998-07       Impact factor: 9.043

Review 2.  The crystallins: genes, proteins and diseases.

Authors:  J Graw
Journal:  Biol Chem       Date:  1997-11       Impact factor: 3.915

Review 3.  Pax genes and organogenesis.

Authors:  E Dahl; H Koseki; R Balling
Journal:  Bioessays       Date:  1997-09       Impact factor: 4.345

4.  Altered aggregation properties of mutant gamma-crystallins cause inherited cataract.

Authors:  Aileen Sandilands; Aileen M Hutcheson; Heather A Long; Alan R Prescott; Gijs Vrensen; Jana Löster; Norman Klopp; Raimund B Lutz; Jochen Graw; Shigeo Masaki; Christopher M Dobson; Cait E MacPhee; Roy A Quinlan
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

Review 5.  Disparities in adult vision health in the United States.

Authors:  April Zambelli-Weiner; John E Crews; David S Friedman
Journal:  Am J Ophthalmol       Date:  2012-05-24       Impact factor: 5.258

6.  Targeted disruption of the mouse alpha A-crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein alpha B-crystallin.

Authors:  J P Brady; D Garland; Y Duglas-Tabor; W G Robison; A Groome; E F Wawrousek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

7.  Chromosomal localization of a new mouse lens opacity gene (lop18)

Authors:  B Chang; N L Hawes; R S Smith; J R Heckenlively; M T Davisson; T H Roderick
Journal:  Genomics       Date:  1996-08-15       Impact factor: 5.736

8.  Hereditary cataracts in the John Rapp inbred strain of Dahl salt-sensitive rat.

Authors:  C E Margo; E P Gomez-Sanchez; R Gstalder
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-08       Impact factor: 4.799

9.  Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats.

Authors:  J P Rapp; H Dene
Journal:  Hypertension       Date:  1985 May-Jun       Impact factor: 10.190

Review 10.  Mineralocorticoids, salt and high blood pressure.

Authors:  E P Gómez-Sánchez; M Zhou; C E Gomez-Sanchez
Journal:  Steroids       Date:  1996-04       Impact factor: 2.668

View more
  7 in total

Review 1.  Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.

Authors:  Claude Szpirer
Journal:  J Biomed Sci       Date:  2020-08-02       Impact factor: 8.410

2.  A mutated CRYGD associated with congenital coralliform cataracts in two Chinese pedigrees.

Authors:  Su-Ping Cai; Lan Lu; Xi-Zhen Wang; Yun Wang; Fen He; Ning Fan; Jing-Ning Weng; Jun-Hua Zhang; Xu-Yang Liu
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

3.  Hypertension and Hypercholesterolemia are Associated with Cataract Development in Patients with Type 2 Diabetes.

Authors:  Martina Tomić; Romano Vrabec; Petar Raštegorac; Spomenka Ljubić; Tomislav Bulum; Dario Rahelić
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-09-03

4.  Newborn mouse lens proteome and its alteration by lysine 6 mutant ubiquitin.

Authors:  Fu Shang; Phillip A Wilmarth; Min-lee Chang; Ke Liu; Larry L David; Maria Andrea Caceres; Eric Wawrousek; Allen Taylor
Journal:  J Proteome Res       Date:  2014-02-21       Impact factor: 4.466

5.  Hypertension and risk of cataract: a meta-analysis.

Authors:  Xiaoning Yu; Danni Lyu; Xinran Dong; Jiliang He; Ke Yao
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

6.  A Novel CRYBB2 Stopgain Mutation Causing Congenital Autosomal Dominant Cataract in a Chinese Family.

Authors:  Yu Zhou; Yaru Zhai; Lulin Huang; Bo Gong; Jie Li; Fang Hao; Zhengzheng Wu; Yi Shi; Yin Yang
Journal:  J Ophthalmol       Date:  2016-11-29       Impact factor: 1.909

7.  QTL mapping of rat blood pressure loci on RNO1 within a homologous region linked to human hypertension on HSA15.

Authors:  Blair Mell; Xi Cheng; Bina Joe
Journal:  PLoS One       Date:  2019-08-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.